New dimensions in ocular pharmacology 1975.
Progress is painful. This is certainly true in drug therapy. No drug in clinical use is devoid of toxicity, and all ophthalmologists are aware that no human being should be exposed to needless risk. On the other hand, the potential harm done to present and future generations by lack of adequate therapy for many diseases makes it imperative that new drugs, despite their associated hazards,continue to be introduced into research and practice. If an ophthalmologist accepts these thoughts, he also must accept a commitment to understand the effect of drugs in disease, the predisposing factors leading to drug reactions and interactions, the effect of disease on drugs, before he uses them.
D000367:Age Factors; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D005123:Eye / Q000187:drug effects*; D005128:Eye Diseases / Q000139:chemically induced; D006801:Humans; D004364:Pharmaceutical Preparations / Q000378:metabolism
D004364:Pharmaceutical Preparations